Bioinformatics Market Overview
Bioinformatics is defined as the application of tools of computation and analysis to the capture and interpretation of biological data. Bioinformatics is essential for the management of data in modern biology and medicine. The growth of the global Bioinformatics market is being improved by the rising application of IT in the healthcare sector along with robust technological advancements. In addition, other factors such as the rising need for integrated data, increasing demand for nucleic acid & protein sequencing, reduction in sequencing cost, and increase in applications of proteomics & genomics are propelling the growth of the global Bioinformatics market.
Furthermore, bioinformatics has applications in fields such as molecular medicine, preventive medicine, gene therapy, and drug development among others. Some of the other application areas include forensic analysis of genetic research for antibiotic resistance, veterinary science, and microbes. Therefore, owing to its largest application base, the bioinformatics market is projected to rise at a considerable rate in the forthcoming years. In addition, drug discovery & development and initiatives from government & private organizations are expected to boost the market growth during the forecast period.
On the downside, lack of skilled personnel, common data formats, and lack of user-friendly tools at cheaper prices are expected to hamper the market growth in the forecast period. Besides this, the growing need for integrated solutions & systems, integration of machine learning & AI in healthcare, and software companies investing in the development of bioinformatics solutions are anticipated to create lucrative opportunities for bioinformatics solution developers.
Covid-19 Impact on Bioinformatics Market
In addition, the current Bioinformatics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Bioinformatics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Bioinformatics Market Segment Overview
Based on technology & services, the bioinformatics platforms segment has the maximum share in the global bioinformatics market in 2019 and is predictable to maintain its supremacy over the forecast period. This can be mainly attributed to increasing platform applications and the need for better tools in drug development. Additionally, rising platform application is attributed to a surge in need from the life science firm for identification and modification of structures. This, in turn, would help in the drug designing process and evaluation of their therapeutic effects. Moreover, efficiency and safety in drug development and discovery lead to an increase in the need for better tools in drug development. This factor is anticipated to fuel the bioinformatics market size in the coming years.
Bioinformatics Market, By Technology & Services
· Metabolomics
· Molecular Phylogenetics
· Transcriptomics
· Proteomics
· Chemoinformatics & Drug design
· Genomics
· Others
Bioinformatics Market, By Sector
· Medical Bioinformatics
· Animal Bioinformatics
· Agriculture Bioinformatics
· Academics
· Others
Bioinformatics Regional Overview
In terms of region, North America and Europe are prominent regions for the global Bioinformatics market. The major factors propelling the growth of the market in these regions are the heavy research and development investment, high adoption of new and advanced technology, and well-structured regulatory outline. Likewise, the Asia Pacific is expected to register the fastest growth during the forecast period. The market is likely to grow in the region due to factors such as a growing literacy rate, increasing awareness regarding bioinformatics among consumers, and rising government funding and initiative for R&D.
Bioinformatics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Bioinformatics Market Competitor overview
Some key developments and strategies adopted by manufacturers in Bioinformatics are highlighted below.
· In July 2021, Kiromic Biopharma, Inc., a pioneer in immuno oncology cellular therapy in solid tumors, announced it has completed the acquisition of InSilico Solutions, leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors.
Bioinformatics Market, Key Players
· Accelrys Inc.
· ID Business Solutions, Ltd.
· Affymetrix Inc.
· CLC bio A/S
· Agilent Technologies Inc.
· GenoLogics Life Sciences Software, Inc.
· Life Technologies Corporation
· Illumina, Inc.
· Thermo Fisher Scientific
· Eurofins Scientific
· Perkinelmer, Inc.
· Qiagen Bioinformatics
· Dnastar
· Waters Corporation
· Sophia Genetics
· Partek
· Biomax Informatics AG
· Wuxi Nextcode
· Beijing Genomics Institute (BGI)
Bioinformatics is defined as the application of tools of computation and analysis to the capture and interpretation of biological data. Bioinformatics is essential for the management of data in modern biology and medicine. The growth of the global Bioinformatics market is being improved by the rising application of IT in the healthcare sector along with robust technological advancements. In addition, other factors such as the rising need for integrated data, increasing demand for nucleic acid & protein sequencing, reduction in sequencing cost, and increase in applications of proteomics & genomics are propelling the growth of the global Bioinformatics market.
Furthermore, bioinformatics has applications in fields such as molecular medicine, preventive medicine, gene therapy, and drug development among others. Some of the other application areas include forensic analysis of genetic research for antibiotic resistance, veterinary science, and microbes. Therefore, owing to its largest application base, the bioinformatics market is projected to rise at a considerable rate in the forthcoming years. In addition, drug discovery & development and initiatives from government & private organizations are expected to boost the market growth during the forecast period.
On the downside, lack of skilled personnel, common data formats, and lack of user-friendly tools at cheaper prices are expected to hamper the market growth in the forecast period. Besides this, the growing need for integrated solutions & systems, integration of machine learning & AI in healthcare, and software companies investing in the development of bioinformatics solutions are anticipated to create lucrative opportunities for bioinformatics solution developers.
Covid-19 Impact on Bioinformatics Market
In addition, the current Bioinformatics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Bioinformatics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Bioinformatics Market Segment Overview
Based on technology & services, the bioinformatics platforms segment has the maximum share in the global bioinformatics market in 2019 and is predictable to maintain its supremacy over the forecast period. This can be mainly attributed to increasing platform applications and the need for better tools in drug development. Additionally, rising platform application is attributed to a surge in need from the life science firm for identification and modification of structures. This, in turn, would help in the drug designing process and evaluation of their therapeutic effects. Moreover, efficiency and safety in drug development and discovery lead to an increase in the need for better tools in drug development. This factor is anticipated to fuel the bioinformatics market size in the coming years.
Bioinformatics Market, By Technology & Services
- Knowledge Management Tools
- Generalized Knowledge Management Tools
- Specialized Knowledge Management Tools
- Bioinformatics Platforms
- Sequence Analysis Platforms
- Sequence Alignment Platforms
- Sequence Manipulation Platforms
- Structural Analysis Platforms
- Others
- Bioinformatics Services
- Sequencing Services
- Database Management
- Data Analysis
- Others
· Metabolomics
· Molecular Phylogenetics
· Transcriptomics
· Proteomics
· Chemoinformatics & Drug design
· Genomics
· Others
Bioinformatics Market, By Sector
· Medical Bioinformatics
· Animal Bioinformatics
· Agriculture Bioinformatics
· Academics
· Others
Bioinformatics Regional Overview
In terms of region, North America and Europe are prominent regions for the global Bioinformatics market. The major factors propelling the growth of the market in these regions are the heavy research and development investment, high adoption of new and advanced technology, and well-structured regulatory outline. Likewise, the Asia Pacific is expected to register the fastest growth during the forecast period. The market is likely to grow in the region due to factors such as a growing literacy rate, increasing awareness regarding bioinformatics among consumers, and rising government funding and initiative for R&D.
Bioinformatics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Bioinformatics Market Competitor overview
Some key developments and strategies adopted by manufacturers in Bioinformatics are highlighted below.
· In July 2021, Kiromic Biopharma, Inc., a pioneer in immuno oncology cellular therapy in solid tumors, announced it has completed the acquisition of InSilico Solutions, leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors.
Bioinformatics Market, Key Players
· Accelrys Inc.
· ID Business Solutions, Ltd.
· Affymetrix Inc.
· CLC bio A/S
· Agilent Technologies Inc.
· GenoLogics Life Sciences Software, Inc.
· Life Technologies Corporation
· Illumina, Inc.
· Thermo Fisher Scientific
· Eurofins Scientific
· Perkinelmer, Inc.
· Qiagen Bioinformatics
· Dnastar
· Waters Corporation
· Sophia Genetics
· Partek
· Biomax Informatics AG
· Wuxi Nextcode
· Beijing Genomics Institute (BGI)
Bioinformatics Market Study Global Market Analysis, Insights and Forecast, 2020-20275.3. Market Analysis, Insights and Forecast – By Application 5.4. Market Analysis, Insights and Forecast – By Sector 5.5. Market Analysis, Insights and Forecast – By Region 6.3. Market Analysis, Insights and Forecast – By Application 6.4. Market Analysis, Insights and Forecast – By Sector 6.5. Market Analysis, Insights and Forecast – By Country 7.3. Market Analysis, Insights and Forecast – By Application 7.4. Market Analysis, Insights and Forecast – By Sector 7.5. Market Analysis, Insights and Forecast – By Country 8.3. Market Analysis, Insights and Forecast – By Application 8.4. Market Analysis, Insights and Forecast – By Sector 8.5. Market Analysis, Insights and Forecast – By Country 9.3. Market Analysis, Insights and Forecast – By Application 9.4. Market Analysis, Insights and Forecast – By Sector 9.5. Market Analysis, Insights and Forecast – By Country
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Bioinformatics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Technology & Services
- 5.2.1. Knowledge Management Tools
- 5.2.1.1. Generalized Knowledge Management Tools
- 5.2.1.2. Specialized Knowledge Management Tools
- 5.2.2. Bioinformatics Platforms
- 5.2.2.1. Sequence Analysis Platforms
- 5.2.2.2. Sequence Alignment Platforms
- 5.2.2.3. Sequence Manipulation Platforms
- 5.2.2.4. Structural Analysis Platforms
- 5.2.2.5. Others
- 5.2.3. Bioinformatics Services
- 5.2.3.1. Sequencing Services
- 5.2.3.2. Database Management
- 5.2.3.3. Data Analysis
- 5.2.3.4. Others
- 5.2.1. Knowledge Management Tools
- 5.3.1. Metabolomics
- 5.3.2. Molecular Phylogenetics
- 5.3.3. Transcriptomics
- 5.3.4. Proteomics
- 5.3.5. Chemoinformatics & Drug design
- 5.3.6. Genomics
- 5.3.7. Others
- 5.4.1. Medical Bioinformatics
- 5.4.2. Animal Bioinformatics
- 5.4.3. Agriculture Bioinformatics
- 5.4.4. Academics
- 5.4.5. Others
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Bioinformatics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Technology & Services
- 6.2.1. Knowledge Management Tools
- 6.2.1.1. Generalized Knowledge Management Tools
- 6.2.1.2. Specialized Knowledge Management Tools
- 6.2.2. Bioinformatics Platforms
- 6.2.2.1. Sequence Analysis Platforms
- 6.2.2.2. Sequence Alignment Platforms
- 6.2.2.3. Sequence Manipulation Platforms
- 6.2.2.4. Structural Analysis Platforms
- 6.2.2.5. Others
- 6.2.3. Bioinformatics Services
- 6.2.3.1. Sequencing Services
- 6.2.3.2. Database Management
- 6.2.3.3. Data Analysis
- 6.2.3.4. Others
- 6.2.1. Knowledge Management Tools
- 6.3.1. Metabolomics
- 6.3.2. Molecular Phylogenetics
- 6.3.3. Transcriptomics
- 6.3.4. Proteomics
- 6.3.5. Chemoinformatics & Drug design
- 6.3.6. Genomics
- 6.3.7. Others
- 6.4.1. Medical Bioinformatics
- 6.4.2. Animal Bioinformatics
- 6.4.3. Agriculture Bioinformatics
- 6.4.4. Academics
- 6.4.5. Others
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Bioinformatics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Technology & Services
- 7.2.1. Knowledge Management Tools
- 7.2.1.1. Generalized Knowledge Management Tools
- 7.2.1.2. Specialized Knowledge Management Tools
- 7.2.2. Bioinformatics Platforms
- 7.2.2.1. Sequence Analysis Platforms
- 7.2.2.2. Sequence Alignment Platforms
- 7.2.2.3. Sequence Manipulation Platforms
- 7.2.2.4. Structural Analysis Platforms
- 7.2.2.5. Others
- 7.2.3. Bioinformatics Services
- 7.2.3.1. Sequencing Services
- 7.2.3.2. Database Management
- 7.2.3.3. Data Analysis
- 7.2.3.4. Others
- 7.2.1. Knowledge Management Tools
- 7.3.1. Metabolomics
- 7.3.2. Molecular Phylogenetics
- 7.3.3. Transcriptomics
- 7.3.4. Proteomics
- 7.3.5. Chemoinformatics & Drug design
- 7.3.6. Genomics
- 7.3.7. Others
- 7.4.1. Medical Bioinformatics
- 7.4.2. Animal Bioinformatics
- 7.4.3. Agriculture Bioinformatics
- 7.4.4. Academics
- 7.4.5. Others
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Bioinformatics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Technology & Services
- 8.2.1. Knowledge Management Tools
- 8.2.1.1. Generalized Knowledge Management Tools
- 8.2.1.2. Specialized Knowledge Management Tools
- 8.2.2. Bioinformatics Platforms
- 8.2.2.1. Sequence Analysis Platforms
- 8.2.2.2. Sequence Alignment Platforms
- 8.2.2.3. Sequence Manipulation Platforms
- 8.2.2.4. Structural Analysis Platforms
- 8.2.2.5. Others
- 8.2.3. Bioinformatics Services
- 8.2.3.1. Sequencing Services
- 8.2.3.2. Database Management
- 8.2.3.3. Data Analysis
- 8.2.3.4. Others
- 8.2.1. Knowledge Management Tools
- 8.3.1. Metabolomics
- 8.3.2. Molecular Phylogenetics
- 8.3.3. Transcriptomics
- 8.3.4. Proteomics
- 8.3.5. Chemoinformatics & Drug design
- 8.3.6. Genomics
- 8.3.7. Others
- 8.4.1. Medical Bioinformatics
- 8.4.2. Animal Bioinformatics
- 8.4.3. Agriculture Bioinformatics
- 8.4.4. Academics
- 8.4.5. Others
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Bioinformatics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Technology & Services
- 9.2.1. Knowledge Management Tools
- 9.2.1.1. Generalized Knowledge Management Tools
- 9.2.1.2. Specialized Knowledge Management Tools
- 9.2.2. Bioinformatics Platforms
- 9.2.2.1. Sequence Analysis Platforms
- 9.2.2.2. Sequence Alignment Platforms
- 9.2.2.3. Sequence Manipulation Platforms
- 9.2.2.4. Structural Analysis Platforms
- 9.2.2.5. Others
- 9.2.3. Bioinformatics Services
- 9.2.3.1. Sequencing Services
- 9.2.3.2. Database Management
- 9.2.3.3. Data Analysis
- 9.2.3.4. Others
- 9.2.1. Knowledge Management Tools
- 9.3.1. Metabolomics
- 9.3.2. Molecular Phylogenetics
- 9.3.3. Transcriptomics
- 9.3.4. Proteomics
- 9.3.5. Chemoinformatics & Drug design
- 9.3.6. Genomics
- 9.3.7. Others
- 9.4.1. Medical Bioinformatics
- 9.4.2. Animal Bioinformatics
- 9.4.3. Agriculture Bioinformatics
- 9.4.4. Academics
- 9.4.5. Others
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Accelrys Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. ID Business Solutions, Ltd.
- 10.6. Affymetrix Inc.
- 10.7. CLC bio A/S
- 10.8. Agilent Technologies Inc.
- 10.9. GenoLogics Life Sciences Software, Inc.
- 10.10. Life Technologies Corporation
- 10.11. Illumina, Inc.
- 10.12. Thermo Fisher Scientific
- 10.13. Eurofins Scientific
- 10.14. Perkinelmer, Inc.
- 10.15. Qiagen Bioinformatics
- 10.16. Dnastar
- 10.17. Waters Corporation
- 10.18. Sophia Genetics
- 10.19. Partek
- 10.20. Biomax Informatics AG
- 10.21. Wuxi Nextcode
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
